Intracerebral Hemorrhage — Cerebellar (emergent decompression)
Phase C shard-3 neuro-sym wave-14 ICH location triplet (2026-05-15): authored at SCAFFOLDED — uses generic workup.ich; no cerebellar-specific surgical cascade in clinical-tools-registry.ts. Same-commit peers: neuro.ich-lobar.v1 + neuro.ich-deep.v1. AHA/ASA 2022 Class I emergent decompression for cerebellar ≥3 cm OR brainstem compression OR obstructive hydrocephalus — life-saving suboccipital decompressive craniectomy; posterior fossa is non-compliant (Cushing reflex = late sign). ICU is the PRIMARY setting — LOW threshold even for small <3 cm because of delayed-deterioration arm. 5 setting playbooks: home (HINTS-positive central → bypass community ED, route to CSC) → ed (STAT NSurg + CT volumetrics + INTERACT3 if stable + reversal) → icu (post-decompression OR observation arm; q1h Cushing reflex × 24 h) → inpatient (cerebellar rehab + AVM management if applicable + phenotype-specific 2° prevention) → outpatient (BP <130/80 + cerebellar rehab continuity + driving eval). 10 severity_triggers: small_cerebellar_lt_3cm_no_brainstem_compression, cerebellar_ge_3cm_or_brainstem_compression_STAT_decompression, cerebellar_with_obstructive_hydrocephalus_EVD, cerebellar_with_GCS_decline_post_admission_STAT_surgery, ataxia_vertigo_predominant (HINTS pivot), cerebellar_AVM_associated, cerebellar_amyloid_overlap, oral_anticoag_associated_cerebellar, SVC_overlap, pediatric_cerebellar_AVM. 6 PMID anchor: AHA/ASA 2022 (35579034), INTERACT3 (37245517), HINTS Newman-Toker 2009 (19762709), ANNEXA-I (38749032), PATCH (27178479), ENRICH (38598795 — explicit non-applicability for cerebellar). Regimen 4-step bundle: STAT decompression Class I; EVD if hydrocephalus; INTERACT3 BP <140 if stable; reversal per anticoag (4F-PCC + vit K for VKA; idarucizumab for dabigatran; andexanet ANNEXA-I low/high for FXa-DOAC). KEY contrast vs lobar/deep: cerebellar is the ONLY ICH phenotype with Class I emergent decompression; ENRICH MIE benefits lobar (NOT cerebellar); supratentorial deep NOT routinely evacuated. Sibling siblings (3, all resolving): neuro.ich.core.v1 (parent PRODUCTION), neuro.ischaemic-stroke.v1 (real PRODUCTION), symptom.vertigo.v1 (real PRODUCTION; HINTS pivot for vestibular presentations). Promotion to INTEGRATED requires cerebellar suboccipital decompressive craniectomy cascade + EVD cascade in clinical-tools-registry.
Entry points (4)
- imagingNon-contrast CT head showing cerebellar intraparenchymal blood (AHA/ASA 2022 PMID 35579034)ct_head_cerebellar_blood
- symptomSudden ataxia + vertigo + vomiting + occipital headache (often mistaken for benign vertigo — HINTS pivot; Newman-Toker Stroke 2009 PMID 19762709)sudden_ataxia_vertigo_vomiting_headache
- symptomAltered consciousness from brainstem compression / hydrocephalus (AHA/ASA 2022)altered_consciousness
- medicationOn VKA / DOAC / heparin at presentation (ANNEXA-I PMID 38749032)current_anticoagulant
Required inputs (11)
- agerequireddemographic • used at CONTEXTPediatric cerebellar ICH often AVM rupture; adult often hypertensive (AHA/ASA 2022)
- sbprequiredvital • used at TREATMENTINTERACT3 (PMID 37245517) target SBP <140 within 1 h if hemodynamically stable; avoid <110 (ATACH-2)
- gcsrequiredvital • used at RED_FLAGSGCS drives ICH score (Hemphill 2001) + intubation + Cushing-reflex monitoring (AHA/ASA 2022)
- ct_head_noncontrastrequiredimaging • used at INITIAL_WORKUPVolume measurement (≥3 cm = STAT surgical indication per AHA/ASA 2022 Class I); brainstem compression; 4th-ventricle compression; obstructive hydrocephalus
- cta_head_spot_signimaging • used at INITIAL_WORKUPSpot sign within 6 h predicts hematoma expansion (AHA/ASA 2022)
- mri_for_underlying_lesionimaging • used at BRANCHING_WORKUPAVM / cavernous malformation / amyloid overlap workup, especially in young / atypical patients
- inrrequiredlab • used at RED_FLAGSVKA reversal threshold; STAT 4F-PCC if INR ≥1.4 (INCH PMID 27302126)
- platelet_countrequiredlab • used at RED_FLAGSCoagulopathy assessment; PATCH (PMID 27178479) — do NOT routinely transfuse
- creatininerequiredlab • used at CONTEXTContrast + dosing decisions; andexanet (ANNEXA-I PMID 38749032)
- current_anticoagulantrequiredmedication • used at TREATMENTVKA → 4F-PCC + vit K (INCH); dabigatran → idarucizumab; FXa-DOAC → andexanet (ANNEXA-I PMID 38749032)
- cerebellar_signs_ataxia_dysmetriasymptom • used at CONTEXTCerebellar dysfunction signs anchor diagnosis when CT preceded by vestibular pivot (HINTS Newman-Toker Stroke 2009 PMID 19762709)
12-phase flow (12)
- 1FRAMECerebellar bleed on CT; assess volume + brainstem compression + 4th-ventricle compression + obstructive hydrocephalus (AHA/ASA 2022 PMID 35579034)advance: Cerebellar ICH confirmed on imaging
- 2ENTRYSudden ataxia / vertigo / vomiting / occipital headache (HINTS pivot — central pattern: ipsilateral vertical or torsional nystagmus, normal head impulse, vertical skew; Newman-Toker Stroke 2009 PMID 19762709)inputs: ageadvance: Cerebellar entry trigger captured; CT ordered
- 3CONTEXTHTN history, anticoag exposure, age, baseline function, AVM history, creatinine (AHA/ASA 2022)inputs: sbp, gcs, creatinine, current_anticoagulant, cerebellar_signs_ataxia_dysmetriaadvance: Context captured + reversal decision-tree primed
- 4RED_FLAGSVolume ≥3 cm OR brainstem compression OR obstructive hydrocephalus → STAT surgical decompression (AHA/ASA 2022 Class I); Cushing reflex; GCS decline post-admission (AHA/ASA 2022)inputs: gcs, inr, platelet_countactions: workup.ichadvance: Surgical decision documented or low-risk observation initiated
- 5INITIAL_WORKUPNon-contrast CT + CTA spot sign; CBC, CMP, coags, type & screen; STAT neurosurgical consult; INTERACT3 BP bundle if otherwise stable (AHA/ASA 2022; PMID 37245517)inputs: ct_head_noncontrast, cta_head_spot_sign, inr, platelet_countactions: panel.renaladvance: Volume + brainstem-compression + 4th-vent + hydrocephalus status documented
- 6BRANCHING_WORKUPMRI for underlying AVM / cavernous malformation / amyloid overlap; DSA if young or atypical (AHA/ASA 2022)inputs: mri_for_underlying_lesionadvance: Mechanism confirmed (chronic HTN vs AVM vs amyloid overlap vs anticoag)
- 7DIFFERENTIALSpontaneous hypertensive cerebellar (most common) vs AVM-associated vs amyloid-overlap (rare cerebellar CAA) vs anticoag-associated vs pediatric AVM rupture (AHA/ASA 2022)advance: Cerebellar mechanism assigned
- 8RISK_STRATIFICATIONVolume ≥3 cm = Class I emergent decompression; brainstem compression markers; ICH score (Hemphill 2001) with infratentorial +1 component (AHA/ASA 2022)inputs: gcsactions: calc.ich_score, calc.funcadvance: Severity + decompression decision documented
- 9TREATMENTSTAT neurosurgery (suboccipital decompressive craniectomy ± evacuation) if ≥3 cm OR brainstem compression OR hydrocephalus (AHA/ASA 2022 Class I); EVD for obstructive hydrocephalus; INTERACT3 BP <140 if hemodynamically stable; reversal per anticoag; observe <3 cm without compression in ICU (AHA/ASA 2022)inputs: sbp, current_anticoagulantadvance: BP at target + reversal complete + surgical disposition decided
- 10DISPOSITIONNeuro-ICU at NSurg-capable centre — LOW threshold even for small <3 cm (posterior fossa non-compliance); transfer if not available (AHA/ASA 2022)inputs: gcsadvance: NCCU bed allocated at NSurg-capable centre
- 11MONITORINGq1h GCS + pupil + Cushing-reflex check × 24 h; continuous arterial BP; repeat CT 6 h or with decline; post-op craniectomy site assessment (AHA/ASA 2022)inputs: gcs, sbp, inradvance: Monitoring plan documented
- 12FOLLOWUPLong-term BP <130/80 (SPRINT-MIND); MRI for underlying vascular cause in young / atypical; phenotype-specific secondary prevention; cerebellar rehab; PHQ-9 + MoCA; driving evaluation (cerebellar ataxia affects driving) (AHA/ASA 2022)advance: Rehab + outpatient stroke clinic + BP plan + driving eval set